MYAMBUTOL TAB 100MG DIN 00127957
Health Canada record
| Active ingredient(s) | ETHAMBUTOL HYDROCHLORIDE 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J04AK02 ETHAMBUTOL |
| Original market date | 31-Dec-1969 |
| Current status date | 14-Jan-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ETHAMBUTOL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00247960 | ETIBI | BAUSCH HEALTH, CANADA INC. | Tablet | ETHAMBUTOL HYDROCHLORIDE 100 MG | Marketed |
| 00247979 | ETIBI | BAUSCH HEALTH, CANADA INC. | Tablet | ETHAMBUTOL HYDROCHLORIDE 400 MG | Marketed |
| 00127965 | MYAMBUTOL TAB 400MG | LEDERLE CYANAMID CANADA INC. | Tablet | ETHAMBUTOL HYDROCHLORIDE 400 MG | Cancelled Post Market |
| 02170078 | MYAMBUTOL TABLETS - 400 MG | WYETH-AYERST CANADA INC. | Tablet | ETHAMBUTOL HYDROCHLORIDE 400 MG | Cancelled Post Market |
International API supply for ETHAMBUTOL HYDROCHLORIDE
2 valid EDQM Certificates of Suitability from 2 holders. 2 active FDA Drug Master Files.
Request a quote for MYAMBUTOL TAB 100MG